Location History:
- Tokyo, JP (2014 - 2017)
- Saitama, JP (2017)
Company Filing History:
5 out of 26 
2 out of 35 
1 out of 7 Years Active: 2014-2017
Title: Fumiko Nomura: A Pioneer in Cancer Therapy Innovations
Introduction
Fumiko Nomura, an inventive force based in Tokyo, Japan, has made significant contributions to the field of cancer therapy through her innovative research and development. With a portfolio of five patents, her work focuses on advanced drug conjugates that aim to improve cancer treatment efficacy and patient outcomes.
Latest Patents
Among her latest patents are two groundbreaking inventions. The first is a drug conjugate that comprises an anti-CDH3 (P-cadherin) antibody. This invention targets cancer cells expressing CDH3, providing a unique approach to efficiently kill these cells. The innovation lies in forming an immune complex by binding the antibody to a chemotherapeutic agent, thus enhancing its therapeutic impact.
The second patent also revolves around an anti-CDH3 humanized antibody, which has altered immunogenicity properties. This patent details a drug conjugate that combines cytotoxic drugs with the antibody, utilizing specific sequences from both heavy and light chain variable regions. Through this innovation, Nomura's work holds the potential to create more effective cancer therapies with fewer side effects.
Career Highlights
Fumiko Nomura has held pivotal positions at prominent organizations such as Perseus Proteomics Inc. and the University of Miyazaki. Her role at these institutions has been instrumental in translating her research ideas into practical applications that can benefit cancer patients worldwide.
Collaborations
Throughout her career, Nomura has collaborated with esteemed colleagues, including Katsuyuki Mitomo and Yoshikazu Kurosawa. These partnerships have enhanced her research capabilities and enabled her to explore the complexities of cancer treatment through a multidisciplinary approach.
Conclusion
Fumiko Nomura’s contributions to the field of cancer therapy represent a fusion of scientific innovation and practical application. Her patents not only showcase her ingenuity as an inventor but also highlight the potential for improved treatment modalities in cancer care. As her work continues to evolve, it paves the way for future advancements in medical science.